Search Results

Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.

• Authors : Patriquin, Christopher J.; Laroche, Vincent; Mack, Johnathan P.

Subjects: PLASMA exchange (Therapeutics); IDIOPATHIC thrombocytopenic purpura; FIBRIN fragment D

• Source: New England Journal of Medicine. 8/26/2021, Vol. 385 Issue 9, p857-859. 3p.

Record details

Renal Improvement in Myeloma with Plasma Exchange.

Subjects: *LETTERS to the editor; *PLASMA exchange (Therapeutics)

• Source: New England Journal of Medicine. 9/15/2011, Vol. 365 Issue 11, p1061-1062. 2p.

Record details

Renal Improvement in Myeloma with Bortezomib plus Plasma Exchange.

• Authors : Burnette, Brian L.¹; Leung, Nelson¹; Rajkumar, S. Vincent¹

Subjects: *PROTEINS; *PLASMA exchange (Therapeutics); *KIDNEY diseases

• Source: New England Journal of Medicine. 6/16/2011, Vol. 364 Issue 24, p2365-2366. 2p. 1 Diagram.

Record details

Troponin T Levels and Abciximab Therapy in Unstable Angina.

• Authors : Lev, Eli I.; Osende, Julio I.; Zaman, Azfar G.

Subjects: LETTERS to the editor; PLASMA exchange (Therapeutics); IMMUNE serums

• Source: New England Journal of Medicine. 09/30/99, Vol. 341 Issue 14, p1084-1085. 1p.

Record details

An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease.

• Authors : Dunn, Billy¹; Stein, Peter¹; Temple, Robert¹

Subjects: *SINUS thrombosis; *ALZHEIMER'S disease; *PLASMA exchange (Therapeutics)

• Source: New England Journal of Medicine. 8/26/2021, Vol. 385 Issue 9, p856-857. 2p.

Record details

ANCA-Associated Vasculitis - Refining Therapy with Plasma Exchange and Glucocorticoids.

• Authors : Derebail, Vimal K.¹; Falk, Ronald J.¹

Subjects: *AUTOIMMUNE diseases; *GLUCOCORTICOIDS; *PLASMA exchange (Therapeutics)

• Source: New England Journal of Medicine. 2/13/2020, Vol. 382 Issue 7, p671-673. 3p.

Record details

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.

• Authors : Scully, M.; Cataland, S. R.; Peyvandi, F.

Subjects: THERAPEUTIC use of fibrinolytic agents; THERAPEUTIC use of immunoglobulins; THROMBOTIC thrombocytopenic purpura treatment

• Source: New England Journal of Medicine. 1/24/2019, Vol. 380 Issue 4, p335-346. 12p.

Record details

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome.

• Authors : Legendre, C. M.; Licht, C.; Muus, P.

Subjects: THROMBOTIC thrombocytopenic purpura; HEMOLYTIC-uremic syndrome; PLASMA exchange (Therapeutics)

• Source: New England Journal of Medicine. 6/6/2013, Vol. 368 Issue 23, p2169-2181. 13p.

Record details

Myasthenia Gravis.

• Authors : Gilhus, Nils E.

Subjects: MYASTHENIA gravis; AUTOIMMUNE disease treatment; SKELETAL muscle

• Source: New England Journal of Medicine. 12/29/2016, Vol. 375 Issue 26, p2570-2581. 12p.

Record details

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.

• Authors : Peyvandi, Flora; Scully, Marie; Hovinga, Johanna A. Kremer

Subjects: THERAPEUTIC use of immunoglobulins; THROMBOTIC thrombocytopenic purpura treatment; BLOOD platelet aggregation

• Source: New England Journal of Medicine. 2/11/2016, Vol. 374 Issue 6, p511-522. 12p.

Record details